169 related articles for article (PubMed ID: 31620896)
41. Pilot Study of Neoadjuvant Chemoradiotherapy with Three Cycles of 5-Fluorouracil Plus Leucovorin for Treatment of Locally Advanced Rectal Cancer.
Lee SJ; Kang BW; Chae YS; Kim HJ; Park SY; Park JS; Choi GS; Kim JG
Ann Surg Oncol; 2016 Mar; 23(3):894-9. PubMed ID: 26714957
[TBL] [Abstract][Full Text] [Related]
42. Rectal cancers with microscopic circumferential resection margin involvement (R1 resections): Survivals, patterns of recurrence, and prognostic factors.
Gravante G; Hemingway D; Stephenson JA; Sharpe D; Osman A; Haines M; Pirjamali V; Sorge R; Yeung JM; Norwood M; Miller A; Boyle K
J Surg Oncol; 2016 Oct; 114(5):642-648. PubMed ID: 27383398
[TBL] [Abstract][Full Text] [Related]
43. Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
Hagemans JAW; Rothbarth J; Kirkels WJ; Boormans JL; van Meerten E; Nuyttens JJME; Madsen EVE; Verhoef C; Burger JWA
Eur J Surg Oncol; 2018 Oct; 44(10):1548-1554. PubMed ID: 30075979
[TBL] [Abstract][Full Text] [Related]
44. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial.
Chua YJ; Barbachano Y; Cunningham D; Oates JR; Brown G; Wotherspoon A; Tait D; Massey A; Tebbutt NC; Chau I
Lancet Oncol; 2010 Mar; 11(3):241-8. PubMed ID: 20106720
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of treatment response and tissue necrosis as prognostic indicators following neoadjuvant chemoradiotherapy in rectal cancer patients.
Jung JH; An HJ; Kim HJ; Lee J; Lee KM; Kim SH; Cho HM; Shim BY
Korean J Intern Med; 2016 Jan; 31(1):134-44. PubMed ID: 26767867
[TBL] [Abstract][Full Text] [Related]
46. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.
Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992
[TBL] [Abstract][Full Text] [Related]
47. Rate of pulmonary metastasis varies with location of rectal cancer in the patients undergoing curative resection.
Lee JL; Yu CS; Kim TW; Kim JH; Kim JC
World J Surg; 2015 Mar; 39(3):759-68. PubMed ID: 25409839
[TBL] [Abstract][Full Text] [Related]
48. Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center.
Zhou J; Qiu H; Lin G; Xiao Y; Wu B; Wu W; Sun X; Lu J; Zhang G; Xu L; Liu Y
Int J Colorectal Dis; 2016 Jun; 31(6):1163-8. PubMed ID: 27044403
[TBL] [Abstract][Full Text] [Related]
49. Effect of long interval between hyperthermochemoradiation therapy and surgery for rectal cancer on apoptosis, proliferation and tumor response.
Kato T; Fujii T; Ide M; Takada T; Sutoh T; Morita H; Yajima R; Yamaguchi S; Tsutsumi S; Asao T; Oyama T; Kuwano H
Anticancer Res; 2014 Jun; 34(6):3141-6. PubMed ID: 24922685
[TBL] [Abstract][Full Text] [Related]
50. Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom?
De Stefano A; Moretto R; Bucci L; Pepe S; Romano FJ; Cella AC; Attademo L; Rosanova M; De Falco S; Fiore G; Raimondo L; De Placido S; Carlomagno C
Clin Colorectal Cancer; 2014 Sep; 13(3):185-91. PubMed ID: 25080847
[TBL] [Abstract][Full Text] [Related]
51. Can serum dynamics of carcinoembryonic antigen level during neoadjuvant chemoradiotherapy in rectal cancer predict tumor response and recurrence? A multi-institutional retrospective study.
Chung MJ; Nam TK; Jeong JU; Kim SH; Kim K; Jang HS; Jeong BK; Lee JH
Int J Colorectal Dis; 2016 Sep; 31(9):1595-601. PubMed ID: 27464635
[TBL] [Abstract][Full Text] [Related]
52. Prognostic relevance of stromal CD26 expression in rectal cancer after chemoradiotherapy.
Saigusa S; Toiyama Y; Tanaka K; Inoue Y; Mori K; Ide S; Imaoka H; Kawamura M; Mohri Y; Kusunoki M
Int J Clin Oncol; 2016 Apr; 21(2):350-358. PubMed ID: 26370256
[TBL] [Abstract][Full Text] [Related]
53. Outcomes of persistent lymph node involvement after neoadjuvant therapy for stage III rectal cancer.
Dinaux AM; Leijssen L; Bordeianou LG; Kunitake H; Amri R; Berger DL
Surgery; 2018 Apr; 163(4):784-788. PubMed ID: 29277386
[TBL] [Abstract][Full Text] [Related]
54. Preliminary results of a cohort study of induction chemotherapy-based treatment for locally recurrent rectal cancer.
van Zoggel DMGI; Bosman SJ; Kusters M; Nieuwenhuijzen GAP; Cnossen JS; Creemers GJ; van Lijnschoten G; Rutten HJT
Br J Surg; 2018 Mar; 105(4):447-452. PubMed ID: 29168556
[TBL] [Abstract][Full Text] [Related]
55. Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy.
Sclafani F; Brown G; Cunningham D; Rao S; Tekkis P; Tait D; Morano F; Baratelli C; Kalaitzaki E; Rasheed S; Watkins D; Starling N; Wotherspoon A; Chau I
Oncologist; 2017 Jun; 22(6):728-736. PubMed ID: 28476941
[TBL] [Abstract][Full Text] [Related]
56. [Rectal cancer: current status of multimodal therapy--when and how?].
Gaedcke J; Liersch T; Hess C; Becker H; Rödel C; Ghadimi BM
Zentralbl Chir; 2011 Aug; 136(4):334-42. PubMed ID: 21863511
[TBL] [Abstract][Full Text] [Related]
57. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
Lopes-Ramos CM; Habr-Gama A; Quevedo Bde S; Felício NM; Bettoni F; Koyama FC; Asprino PF; Galante PA; Gama-Rodrigues J; Camargo AA; Perez RO; Parmigiani RB
BMC Med Genomics; 2014 Dec; 7():68. PubMed ID: 25496125
[TBL] [Abstract][Full Text] [Related]
58. Quality of life in non-early rectal cancer treated by neoadjuvant radio-chemotherapy and endoluminal loco-regional resection (ELRR) by transanal endoscopic microsurgery (TEM) versus laparoscopic total mesorectal excision.
D'Ambrosio G; Paganini AM; Balla A; Quaresima S; Ursi P; Bruzzone P; Picchetto A; Mattei FI; Lezoche E
Surg Endosc; 2016 Feb; 30(2):504-511. PubMed ID: 26045097
[TBL] [Abstract][Full Text] [Related]
59. One-level step section histological analysis is insufficient to confirm complete pathological response after neoadjuvant chemoradiation for rectal cancer.
Pereira MA; Dias AR; Faraj SF; Nahas CSR; Imperiale AR; Marques CFS; Cotti GC; Azevedo BC; Nahas SC; de Mello ES; Ribeiro U
Tech Coloproctol; 2017 Sep; 21(9):745-754. PubMed ID: 28819868
[TBL] [Abstract][Full Text] [Related]
60. Observation of "complete clinical response" in rectal cancer after neoadjuvant chemoradiation: The Flinders experience.
Sposato LA; Lam Y; Karapetis C; Vatandoust S; Roy A; Hakendorf P; Dwyer A; de Fontgalland D; Hollington P; Wattchow D
Asia Pac J Clin Oncol; 2018 Dec; 14(6):439-445. PubMed ID: 29932278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
